Table 2

Detection of CAD/Risk Assessment Without Ischemic Equivalent

IndicationAppropriate Use Score (1–9)
Asymptomatic
12.
  • Low CHD risk (ATP III risk criteria)

I (1)
13.
  • Intermediate CHD risk (ATP III risk criteria)

  • ECG interpretable

I (3)
14.
  • Intermediate CHD risk (ATP III risk criteria)

  • ECG uninterpretable

U (5)
15.
  • High CHD risk (ATP III risk criteria)

A (7)
New-Onset or Newly Diagnosed Heart Failure With LV Systolic Dysfunction Without Ischemic Equivalent
16.
  • No prior CAD evaluation AND no planned coronary angiography

A (8)
New-Onset Atrial Fibrillation
17.
  • Part of evaluation when etiology unclear

U (6)
Ventricular Tachycardia
18.
  • Low CHD risk (ATP III risk criteria)

A (7)
19.
  • Intermediate or high CHD risk (ATP III risk criteria)

A (8)
Syncope
20.
  • Low CHD risk (ATP III risk criteria)

I (3)
21.
  • Intermediate or high CHD risk (ATP III risk criteria)

A (7)
Elevated Troponin
22.
  • Troponin elevation without additional evidence of acute coronary syndrome

A (7)